RNF168 and cancer: In addition, consistent with the increased cancer risk in Rnf8 but not Rnf168 deficient background [14], [28], Rnf8−/−p53−/− mice developed tumors with a significantly shorter latency compared to Rnf168−/−p53−/− mice.